SCHEMBL13623253

SCHEMBL13623253

c1ccc(N2c3ccccc3CCc3cc(-c4ccc(-c5ccc6c(c5)CCc5ccccc5N6c5ccccc5)cc4)ccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 2/20 0.48
HPGD P15428 1/20 0.46
SRD5A1 P18405 1/20 0.43
ADRA2A P08913 2/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
FAAH O00519 2/20 0.39
MGLL Q99685 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSP90AA1 P07900 1/20 0.39
PKM P14618 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CYP17A1 P05093 2/20 0.37
CYP19A1 P11511 2/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13623258 0.87 HPGD (0.41) HSD17B3HPGDSRD5A1ADRA2AADRA2B
SCHEMBL13623260 0.87 HPGD (0.41) HSD17B3HPGDSRD5A1ADRA2AADRA2B
SCHEMBL2208353 0.85 HPGD (0.46) HSD17B3HPGDADRA2AADRA2BADRA2C
SCHEMBL13158706 0.85 HSD17B3 (0.41) HSD17B3HPGDSRD5A1ADRA2AADRA2B
SCHEMBL14281334 0.85 HPGD (0.59) HSD17B3HPGDADRA2AADRA2BADRA2C
SCHEMBL12414461 0.84 HSD17B3 (0.46) HSD17B3HPGDSRD5A1ADRA2AADRA2B
SCHEMBL14595498 0.84 HSD17B3 (0.46) HSD17B3HPGDSRD5A1ADRA2AADRA2B
SCHEMBL6123811 0.84 HPGD (0.56) HSD17B3HPGDSRD5A1ADRA2AADRA2B
SCHEMBL12414465 0.84 HPGD (0.42) HSD17B3HPGDADRA2AADRA2BADRA2C
SCHEMBL13623251 0.83 HSP90AA1 (0.45) HSD17B3HPGDSRD5A1ALDH1A1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-7619246-B2 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2009-11-17 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070176541-A1 Organic light emitting compound and organic light emitting device comprising the same C1S, OR10J3, C1R HSD17B3 1258/4885HPGD 3468/4885SRD5A1 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.